Stockscreener 앱 받기
0.57
11.21%
-0.072
시간 외 거래:
.62
0.05
+8.77%
전일 마감가:
$0.642
열려 있는:
$0.63
하루 거래량:
529.87K
Relative Volume:
1.10
시가총액:
$3.98M
수익:
$513.90K
순이익/손실:
$-48.50M
주가수익비율:
-0.0203
EPS:
-28.0101
순현금흐름:
$-28.99M
1주 성능:
-20.29%
1개월 성능:
-47.22%
6개월 성능:
-66.27%
1년 성능:
-94.04%
1일 변동 폭
$0.5572
$0.65
1주일 범위
$0.5572
$0.7499
52주 변동 폭
$0.5572
$46.50
Co Diagnostics Inc Stock (CODX) Company Profile
명칭
Co Diagnostics Inc
전화
(801) 438-1036
주소
2401 S FOOTHILL DRIVE, SALT LAKE CITY
Compare CODX vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
0.57 | 3.98M | 513.90K | -48.50M | -28.99M | -28.01 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-12 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2021-12-29 | 개시 | Sidoti | Buy |
| 2021-03-29 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2020-05-20 | 업그레이드 | Maxim Group | Hold → Buy |
| 2020-05-18 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-09 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-03 | 다운그레이드 | Maxim Group | Buy → Hold |
모두보기
Co Diagnostics Inc 주식(CODX)의 최신 뉴스
Nine proposals face a court-ordered Co-Diagnostics (CODX) vote, including reverse-split authority. - Stock Titan
Co-Diagnostics taps J.J. Astor for $2.1M convertible loan to fund operations - Dealroom
Dwight Evans Stock Trades and Disclosures - TechGraph
Daniel S Sullivan Stock Trades and Disclosures - TechGraph
Co-Diagnostics (Nasdaq:CODX)Stock Analysis - simplywall.st
Co-Diagnostics, Inc. (CODX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Up to 1-for-50 reverse split on table at Co-Diagnostics (NASDAQ: CODX) - Stock Titan
Ebola outbreak is focus of a New York health roundtable. Co-Dx will join. - Stock Titan
Co-Diagnostics to Hold Press Conference - Yahoo Finance
Co-Diagnostics (CODX) finance EVP details RSU grants vesting through 2028 - Stock Titan
Q1 2026 Co-Diagnostics Inc Earnings Call Transcript - GuruFocus
CeriBell, Inc.Common Stock (CBLL) Stock Price, News, Quote & History - FinancialContent
Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida - PR Newswire
United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday - Benzinga
Weekly Recap: International Vector Smart kit deployment and CFO resignation - TradingView
Co-Diagnostics, Inc. Announces Executive Changes, Effective September 2, 2026 - marketscreener.com
CODX Looks 32.6% Undervalued on GF Value™ Amid Challenging Funda - GuruFocus
Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India - Morningstar
Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India - Yahoo Finance
Co-Diagnostics, Inc. SEC Filing (Sep 2, 2026) - Stock Titan
CODX Looks 31.4% Undervalued on GF Value™ - GuruFocus
A mosquito surveillance system reaches an overseas U.S. Air Force base - Stock Titan
Quest Diagnostics (NYSE: DGX) holder to sell 22,677 shares - Stock Titan
Co-Diagnostics Inc. (CODX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Co-Diagnostics Inc (CODX) Stock News Today - TradingKey
CODX Forecast — Price Target — Prediction for 2027 - tradingview.com
ARMISTICE CAPITAL, LLC Buys Co-Diagnostics Inc (CODX) -- Shares Look 33% Undervalued on GF Value - GuruFocus
Co-Dx (CODX) Q2 2026 Earnings Call Transcript - The Globe and Mail
Co-diagnostics Company Profile & Introduction - Moomoo
Co-Dx (CODX) Q2 2026 Earnings Call Transcript - The Globe and Mail
Co-Diagnostics (CODX) Snapshot: Ends Up by 4.37% at $1.31 in the Current Update; Chart View - vinanet.vn
Co-Diagnostics (CODX) Financial Results: EPS Falls Short of Its Estimate for This Review; Price Reaction: Shares Move 5.97% Lower in the Available RecordEarnings Call Q&A - vinanet.vn
Co-Diagnostics seeks FDA clearance for new PCR Flu A/B & RSV test, prepping for U.S. launch. - Pluang
Co-Diagnostics joins Utah roundtable on AI and medical devices - Stock Titan
Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event - PR Newswire
Maxim Group Upgrades Co-Diagnostics to Buy From Hold, $4 Price Target - marketscreener.com
Company-diagnostics Stock Price Forecast. Should You Buy CODX? - StockInvest.us
Co-Diagnostics Inc (CODX) Stock News Today - TradingKey
Armistice Capital discloses 9.99% Co-Diagnostics (CODX) holding via Master Fund - Stock Titan
Co-diagnostics | SCHEDULE 13G: Others - Moomoo
Co-Diagnostics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Co-diagnostics(CODX) Stock Options Chain | Quotes & News - Moomoo
Co-Diagnostics (CODX) Earnings Call Q2 2026: FDA-Antrag schreitet voran, während Barmittel sinken - TradingKey
Co-Diagnostics (CODX) Q2 2026 Earnings Call: FDA Filing Advances as Cash Falls - TradingKey
Co-Diagnostics Inc (CODX) (Q2 2026) Earnings Call Highlights: FD - GuruFocus
Co-Diagnostics Inc (CODX) (Q2 2026) Earnings Call Highlights: FD - GuruFocus
Is Co-Diagnostics Inc (CODX) Undervalued Despite Q2 Earnings Mis - GuruFocus
Co-Diagnostics Q2 Results: Net loss narrows to $6.3 million - scanx.trade
Co-Diagnostics Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
Earnings call transcript: Co-Diagnostics narrows loss in Q2 2026 but revenue stays thin - Investing.com
Co Diagnostics Inc (CODX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.37%
7.41%
자본화:
|
볼륨(24시간):